Progesterone-Containing Gel Does Not Eliminate Postpartum Breast Engorgement?

Area of Science:

• Obstetrics and Gynecology
• Lactation and Breastfeeding
• Dermatology

Background:

• Severe postpartum breast engorgement causes significant maternal discomfort.
• Engorgement can impede infant breastfeeding success.
• Investigating novel treatments for postpartum breast engorgement is crucial.

Purpose of the Study:

• To evaluate the efficacy of percutaneous progesterone-containing gel (Progestogel) in resolving severe postpartum breast engorgement.
• To determine if transdermal Progestogel application can reduce breast swelling, engorgement, and tenderness.

Main Methods:

• A study involving 23 lactating women experiencing severe postpartum breast engorgement.
• Transdermal application of 2.5-3g of Progestogel to the breast.
• Measurement of mammary gland density using a tonometer before and 20 minutes after gel application.

Main Results:

• Application of Progestogel did not lead to a reduction in breast swelling.
• No significant decrease in breast engorgement or tenderness was observed within 20 minutes.
• Tonometer readings indicated no change in mammary gland density post-application.

Conclusions:

• Transdermal application of Progestogel is ineffective in reducing postpartum breast engorgement.
• The study did not support the use of Progestogel for managing severe breast engorgement in lactating women.
• Further research may be needed to explore alternative treatments for this condition.